Professional Documents
Culture Documents
PubMed Central, Table 2 - Nutr Rev. 2021 Jun 79 (6) - 627-635. Published Online 2020 Sep 25. Doi - 10.1093 - Nutrit - Nuaa095
PubMed Central, Table 2 - Nutr Rev. 2021 Jun 79 (6) - 627-635. Published Online 2020 Sep 25. Doi - 10.1093 - Nutrit - Nuaa095
2: Nutr Rev. 2021 Jun; 79(6): 627–635. Published online 2020 Sep 25. doi: 10.1093/nutrit/nuaa095
Table 2
Effect of drug use and treatment methods on the nutritional status
Macro- and Higher energy, proteins, and carbohydrates after Higher energy, proteins, and carbohydrates
Deficits in energy and protein
micronutrient initiation of treatments, with a decrease in later after initiation of treatments, with a decrease
intake Majority of vitamins and minerals below RI stages in later stages.
Plasma nutrients Majority of micronutrient levels stayed below the Majority of micronutrient levels stayed below
Low levels of Se, K, Fe, vitamins A, D, C, and E
recommended levels. the recommended levels.
High levels of Mg, Na, and Ph attributed to
dehydration
Anthropometrics Decrease in BMI and weight with variations Significant increase in BMI and weight, with more Increase in weight and food intake in early
based on the type of drug significance in women, placing them in the stages of recovery
overweight category.
Metabolic Low levels of total and HDL-cholesterol, leptin, Increase in total and HDL-cholesterol and leptin
parameters FBS, Hct, and Hb levels
Abbreviations: BMI, body mass index; FBS, fasting blood sugar; Fe, iron; Hb, hemoglobin; Hct, hematocrit; HDL, high-density lipoprotein; K, potassium; Mg, magnesium;
Na, sodium; OST, opioid substitution treatment; Ph, phosphorus; RI, recommended intake; Se, selenium.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114851/table/nuaa095-T2/?report=objectonly 1/1